Clinical Efficacy and Safety Evaluation of HCP1202 in COPD Patients

Clinical trial NCT02941679 · UNKNOWN

Trial details

NCT number: NCT02941679
Sponsor: Hanmi Pharmaceutical Company Limited
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2016-10-01
Primary completion: 2018-02-01
Enrollment: 252

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.